The Qualitalks Podcast

Imagine missing a critical air‑handler failure because your BMS drowns you in 1,400 daily alarms—Stephen Tierney, President of Xiltrix, reveals how an independent EMS can turn blind spots into compliance‑savvy insights for pharma, biotech, and med‑tech. Yan Kugel then explores real‑world sensor placement, AI‑driven pattern detection, and the human‑in‑the‑loop strategy that lets quality leaders prevent costly downtime.-----------------------------------------------------------This episode is supported by XiltriX . They provide 24/7 live agent monitoring for biotech and biopharma labs and facilities that need to prevent sample loss and maintain compliance------------------------------------------------------------------------------------------------------------------------------Connect with us:☑ Podcast: https://podcast.qualistery.com☑ Facebook: https://www.facebook.com/Qualistery/☑ LinkedIn: https://www.linkedin.com/company/68350215☑ Twitter: https://twitter.com/qualisteryVisit ⁠⁠www.qualistery.com⁠⁠ for live free webinars for GxP professionals, to stay on top of the latest industry trends.

Imagine unlocking 20 years of QC data to let AI forecast instrument downtime. John Welsh of Agilent reveals how the Allotrope simplified model and modern lab informatics turn compliance into a competitive edge. Discover why regulated pharma, biotech and med‑tech leaders can’t afford to ignore this shift.-------------------------Episode Sponsor: Agilent is a global leader in life sciences, diagnostics and applied markets, recognized for uncompromising integrity in all we do. Our mission is to advance quality of life by focusing our expertise in six key markets: Food, Environmental and Forensics, Pharmaceutical, Diagnostics, Chemical and Advanced Materials and Research.-------------------------Want to stay current with the latest GxP trends? Join our free, enlightening certification webinars at ⁠⁠www.qualistery.com⁠⁠.-------------------------For guest or sponsorship inquiries, contact us at [email protected]

In this episode, Yan Kugel and Konrad Sägesser discuss the latest trends and practical solutions in pharmaceutical water quality monitoring. Learn how continuous analytics, compliance, sustainability, and AI are reshaping water management in pharma manufacturing.Konrad is a Key Account Manager at Swan Analytical Instruments. He is a subject matter expert and co-author of the A3P Guidelines, alongside industry experts from Sanofi, BWT, and Veolia.

Can a single click replace years of tech transfer paperwork? Nikki Bishop, VP of Marketing & Experience at Emerson , reveals how AI‑driven digitization could slash delays for pharma, biotech, med‑tech, and other regulated manufacturers.-------------------------Episode Sponsor: Emerson is a global leader in automation technology and industrial software, providing innovative solutions that help life sciences manufacturers optimize operations, enhance efficiency, and ensure regulatory compliance. With a focus on digital transformation, Emerson enables smarter, data-driven decision-making to drive productivity, quality, and sustainable growth in highly regulated industries.-------------------------Want to stay current with the latest GxP trends? Join our free, enlightening certification webinars at ⁠www.qualistery.com⁠.-------------------------For guest or sponsorship inquiries, contact us at [email protected]

Can custom active‑packaging technology add three years to a drug’s shelf life?Badre E. Hammond, Global VP of Aptar Active Material Science, reveals how early‑stage material science can slash development time, meet FDA/EMA requirements, and neutralize nitrosamine risks for pharma, biotech, and med‑tech leaders.Episode sponsor: Aptar Active Material Science is a premier active material science solutions expert that transforms ideas into market opportunities, accelerates and de-risks the product development process.-------------------------Want to stay current with the latest GxP trends? Join our free, enlightening certification webinars at www.qualistery.com.

Process Analytical Technology (PAT) has evolved from a niche troubleshooting tool into a strategic necessity—but most companies still implement it too late.  Dr. Stanislav Kazakov from Thermo Fisher Scientific reveals why starting PAT early can mean the difference between scaling success and costly manufacturing failures.Discover how real-time process insights, AI-driven chemometrics, and strategic implementation are reshaping quality control from lab to commercial scale across pharma and biotech.----------------------This episode is supported by Thermo Fisher Scientific. partners across the drug lifecycle to accelerate discovery, scale manufacturing, and ensure compliant release. Our analytical and process technologies support pharmaceutical and biotech teams from research and formulation through commercial manufacturing and quality control. With integrated instrumentation, workflow solutions, and expert service, we help protect yield, ensure data integrity, and deliver therapies to patients with confidence.----------------------Visit ⁠www.qualistery.com⁠ for live free webinars for GxP professionals, to stay on top of the latest industry trends.

What does it take to keep pharma & biotech CDMOs inspection‑ready across global sites? Senior VP of Global Quality, Melanie Kearney, reveals how she transforms quality culture, bridges R&D and manufacturing, and turns audits into a competitive advantage.The episode is supported by OXB. OXB is a quality and innovation-led viral vector CDMO, supporting its clients in delivering their life-changing therapies to patients around the world.--------------------------------------------Visit www.qualistery.com for live free webinars for GxP professionals, to stay on top of the latest industry trends.

Yan Kugel is joined by Elizabeth Hickman, the CEO at AustinPx. With over a decade of experience in the biotech and pharmaceutical sectors, Elizabeth shares her insights on drug development, innovative manufacturing solutions, and the pressing need for sustainability in pharma.

In this episode, Yan Kugel is joined by Will Moss founder and CEO of Seal, about the critical need for automation in GXP processes. Will shares his expertise on balancing automation with human oversight, addressing data privacy concerns, and the future of quality management in the pharmaceutical sector.

In this episode, Yan Kugel is joined by Christy Mazzarisi, a distinguished leader in the pharmaceutical industry with extensive experience in quality systems and leadership roles. In this episode, we explore Christy's journey in pharma, her works, her impact on advocacy and leadership, and her vision for empowering women in the pharmaceutical industry.